Emerging role of transplantation for primary liver cancers

Cancer Journal

Volumn 10, Issue 2, 2004, Pages 88-96

  Nissen, Nicholas N ^a   Cavazzoni, Emanuel ^a   Tran, Tram T ^a   Poordad, Fred P ^a  

^a Cedars Sinai Medical Center ^*  (United States)

Author keywords

Hepatecellular cancer; Liver transplantation; MELD; Primary hepatic cancer

Indexed keywords

ADJUVANT THERAPY; BILE DUCT CARCINOMA; CANCER SURVIVAL; HEMANGIOENDOTHELIOMA; HEPATITIS C; HEPATOBLASTOMA; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; ORGAN DONOR; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; UNITED STATES; ALGORITHM; DRUG CONTRAINDICATION; LIVER CELL CARCINOMA; LIVER TUMOR;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HEMANGIOENDOTHELIOMA, EPITHELIOID; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 4444234140     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200403000-00004     Document Type: Review

References (54)

1. United Network for Organ Sharing Website. U.S. Transplantation Data. www.unos.org/data/default/asp?displayType = usdata. Accessed 2/3/2004.
2. Trotter JF, Wachs M, Everson G et al. Adult-to adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002; 346:1074-1082.
3. El-Sarag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
4. Starzl TE. Experience in Hepatic Transplantation. Philadelphia: WB Saunders, 1969:350-355.
5. Ringe B, Wittekind O, Bechstein WO et al. The role of liver transplantation in hepatobiliary malignancy. Ann Surg 1989;209:88-98.
6. Hwan YY, Cary HP, Geschwind J et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1987 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003;21:4329-4335.
7. Poon RT, Fan ST, Lo CM et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function. Ann Surg 2002;235:373-382.
8. Llovet JM, FusterJ, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection vs. transplantation. Hepatology 1999;30:1434-1440.
9. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
10. Yao FY, Ferrel L, Bas NM et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
11. Yao FY, Ferrel L, Bas NM et al. Liver transplantation for hepatocel-lular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:756-774.
12. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristic on outcome. Ann Surg 1998;228:479-490.
13. Iwatsuki S, Starzl TE, Shearman DG et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-229.
14. Khakhar A, Solano E, Stell D et al. Survival after liver transplantation for hepatocellular carcinoma. Transpl Proc 2003;35:2438-2441.
15. Otto G, Heuschen U, Hofmann WJ et al. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg 1998;227:424-432.
16. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
17. Yamamoto J, Iwatsuki S, Kosuge T et al. Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999; 86:1151-1158.
18. Majno PE, Sarasin FP, Menta G et al. Primary liver resection and salvage transplantation of primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome oriented decision analysis. Hepatology 2000; 31:899-906.
19. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995;75:171-190.
20. Kluge R, Schmidt F, Caca K et al. Positron emission tomography with [(18)F] fluoro-2-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 1995;33:1029-1035.
21. Rullier A, LeBail B, Fawaz R et al. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 2000;24:870-876.
22. Patel AH, Harnois DM, Klee GG et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000;95:204-207.
23. Rosen CB, Nagomey DM, Wiesner RH et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21-25.
24. Yamanaka N, Okamoio E, Ando T et al. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995;76:2449-2456.
25. Molmenti EP, Marsh JW, Dvorchik I et al. Hepatobiliary malignancies: primary hepatic malignant neoplasms [review]. Surg Clin North Am 1999;79:43-57, viii.
26. Harrison LE, Fong Y, Klimstra DS et al. Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 1998;85:1068-1070.
27. Pichlmayr R, Lamesch P, Weimann A et al. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995;19:83-88.
28. Berdah SV, Delpero JR, Garcia S et al. A Western surgical experience of peripheral cholangiocarcinoma. Br J Surg 1996;83:1517-1521.
29. Yamamoto J, Kosuge T, Takayama T et al. Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery 1992;111:617-622.
30. Kawarada Y, Mizumoto R. Diagnosis and treatment of cholangio-cellular carcinoma of the liver. Hepatogastroenterology 1990;37:176-181.
31. Burke EC, Jarnagin WR, Hochwald SN et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385-394.
32. Nimura Y, Hayakama N, Kamiya J et al. Hilar cholangiocarcinoma: surgical anatomy and curative resection. J Hepatobiliary Pancreat Surg 1995;2:239-248.
33. Neuhaus P, Jonas S, Bechstein WO et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999;230:808-819.
34. Iwatsuki S, Todo S, Marsh JW et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998;187:358-364.
35. Pichlmayr R, Weimann A, Klempnauer J et al. Surgical treatment in proximal bile duct cancer: a single-center experience. Ann Surg 1996;224:628-663.
36. Nakeeb A, Pitt HA, Pohn TA et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar and distal tumors. Ann Surg 1996;224:463-475.
37. Strong RW, Lynch SV Surgical resection for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 1995;2:233-238.
38. Nakoagohri T, Asano T, Kinoshita H et al. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg 2003;27:289-293.
39. Pichlmayr R, Lamesch P, Weimann A et al. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995;19:83-88.
40. Burke EC, Jamagin WR, Hochwald SN et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385-394.
41. Haug CE, Jenkins RL, Rohrer RJ et al. Liver transplantation for primary hepatic cancer. Transplantation 1992;53:376-382.
42. Chung SW, Greig PD, Cattral MS et al. Evaluation of liver transplantation for high-risk indications. Br J Surg 1997;84:189-195.
43. Jonas S, Kling N, Guckelberger O et al. Orthotopic liver transplantation after extended bile duct resection as treatment of hilar cholangiocarcinoma: first long-term results. Transpl Int 1998; 11[suppl 1]:S206-208.
44. De Vreede I, Steers JL, Burch PA et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000;6:309-316.
45. Hassoun Z, Gores GJ, Roen CB. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surg Oncol Clin North Am 2002;11:909-921.
46. Figueras J, Llado L, Valls C et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 2000; 6:786-794.
47. Robles R, Figueras J, Turrion VS et al. Liver transplantation for hilar cholangiocarcinoma: Spanish experience. Transplant Proc 2003;35:1821-1822.
48. Robles R, Figueras J, Turrion V et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004;239:265-271.
49. Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver. Cancer 1999;85:562-582.
50. Ben-Haim M, Roayaie S, Ye MQ et al. Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg 1999;5:526-531.
51. Kelleher MB, Iwatsuki S, Sheahan DG. Epithelioid hemangioendothelioma of liver: clinicopathological correlation of 10 cases treated by orthotopic liver transplantation. Am J Surg Pathol 1989;13:999-1008.
52. Reyes JD, Dvorchik I, Kocoshis S et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000;136:795-804.
53. Molmenti EP, Wilkinson K, Molmenti H et al. Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transpl 2002;2:535-538.
54. Pimpalwar AP, Sharif K, Ramani P et al. Strategy for hepatoblastoma management: transplant versus nontransplant surgery. J Pediatr Surg 2001;37:240-245.